The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Esterline Technologies's revenues will compress -1.1% and EPS will contract -38.8%.
The average estimate for revenue is $465.8 million. On the bottom line, the average EPS estimate is $0.60.
Last quarter, Esterline Technologies reported revenue of $530.7 million. GAAP reported sales were 5.6% higher than the prior-year quarter's $502.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $2.17. GAAP EPS of $1.97 for Q4 were 218% higher than the prior-year quarter's $0.62 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 38.5%, 140 basis points better than the prior-year quarter. Operating margin was 16.3%, 70 basis points better than the prior-year quarter. Net margin was 11.6%, 770 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $2.07 billion. The average EPS estimate is $5.56.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 151 members out of 158 rating the stock outperform, and seven members rating it underperform. Among 51 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 49 give Esterline Technologies a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Esterline Technologies is outperform, with an average price target of $70.25.
Looking for alternatives to Esterline Technologies? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Esterline Technologies to My Watchlist.